Genprex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Genprex, Inc. (GNPX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 8.25K shares, a 88.94% decline from fiscal 2022.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 74.60K shares, a 97.04% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-13 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 0.00 shares 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-14 | 0.00 shares 10-Q · filed 2025-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-13 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-13 | |||||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 0.00 shares 10-Q · filed 2025-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-14 | |||||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2025-08-14 | 5.00K shares derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-12 | 5.00K shares derived: sum of 3 quarters · filed 2025-05-12 | 6.19K shares derived: sum of 4 quarters · filed 2025-05-12 | |||||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 5.00K shares derived: sum of 2 quarters · filed 2025-04-01 | 6.19K shares derived: sum of 3 quarters · filed 2025-04-01 | 8.25K shares 10-K · filed 2025-04-01 | |||||
| 2023-09-30 | 5.00K shares 10-Q · filed 2024-11-13 | 6.19K shares derived: sum of 2 quarters · filed 2024-11-13 | 8.25K shares 10-Q · filed 2024-11-13 | 200.00K shares 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 1.19K shares 10-Q · filed 2024-11-13 | 47.50K shares 10-Q · filed 2023-08-21 | 3.25K shares 10-Q · filed 2024-08-09 | 130.00K shares 10-Q · filed 2023-08-21 | |||||
| 2023-03-31 | 2.06K shares 10-Q · filed 2024-11-13 | 82.50K shares 10-Q · filed 2023-05-22 | |||||||
| 2023-03-30 | 82.50K shares 10-Q · filed 2023-08-21 | -2.74M shares derived: sum of 2 quarters · filed 2024-04-01 | -2.74M shares derived: sum of 3 quarters · filed 2024-04-01 | -2.25M shares derived: sum of 4 quarters · filed 2024-04-01 | |||||
| 2022-12-31 | -2.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -2.82M shares derived: sum of 2 quarters · filed 2024-04-01 | -2.33M shares derived: sum of 3 quarters · filed 2024-04-01 | 74.60K shares 10-K · filed 2024-04-01 | 2.98M shares 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | 9.00K shares 10-Q · filed 2023-11-14 | 496.60K shares derived: sum of 2 quarters · filed 2023-11-14 | 2.90M shares 10-Q · filed 2023-11-14 | 2.90M shares derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2022-06-30 | 487.60K shares 10-Q · filed 2023-11-14 | 2.89M shares 10-Q · filed 2023-08-21 | 2.89M shares derived: sum of 3 quarters · filed 2023-11-14 | 3.91M shares derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2022-03-31 | 2.40M shares 10-Q · filed 2023-11-14 | 2.40M shares derived: sum of 2 quarters · filed 2023-11-14 | 3.42M shares derived: sum of 3 quarters · filed 2023-11-14 | 3.59M shares derived: sum of 4 quarters · filed 2023-11-14 | |||||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 1.02M shares derived: sum of 2 quarters · filed 2023-03-31 | 1.19M shares derived: sum of 3 quarters · filed 2023-03-31 | 2.52M shares 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | 1.02M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 1.19M shares derived: sum of 2 quarters · filed 2021-11-15 | 2.52M shares 10-Q · filed 2021-11-15 | 2.84M shares derived: sum of 4 quarters · filed 2022-03-30 | |||||
| 2021-06-30 | 167.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | 1.50M shares 10-Q · filed 2021-08-13 | 1.82M shares derived: sum of 3 quarters · filed 2022-03-30 | 2.75M shares derived: sum of 4 quarters · filed 2022-03-30 | |||||
| 2021-03-31 | 1.33M shares 10-Q · filed 2021-05-17 | 1.66M shares derived: sum of 2 quarters · filed 2022-03-30 | 2.58M shares derived: sum of 3 quarters · filed 2022-03-30 | 2.63M shares derived: sum of 4 quarters · filed 2022-03-30 | |||||
| 2020-12-31 | 2.47M shares 10-Q · filed 2021-05-17 | 325.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 1.25M shares derived: sum of 2 quarters · filed 2022-03-30 | 1.30M shares derived: sum of 3 quarters · filed 2022-03-30 | 2.47M shares 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | 926.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 976.20K shares derived: sum of 2 quarters · filed 2020-11-12 | 2.14M shares 10-Q · filed 2020-11-12 | 2.42M shares derived: sum of 4 quarters · filed 2021-03-26 | |||||
| 2020-06-30 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | 1.22M shares 10-Q · filed 2020-08-11 | 1.50M shares derived: sum of 3 quarters · filed 2021-03-26 | 1.50M shares derived: sum of 4 quarters · filed 2021-03-26 | |||||
| 2020-03-31 | 1.17M shares 10-Q · filed 2020-05-14 | 1.45M shares derived: sum of 2 quarters · filed 2021-03-26 | 1.45M shares derived: sum of 3 quarters · filed 2021-03-26 | 1.45M shares derived: sum of 4 quarters · filed 2021-03-26 | |||||
| 2019-12-31 | 282.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | 282.58K shares derived: sum of 2 quarters · filed 2021-03-26 | 282.58K shares derived: sum of 3 quarters · filed 2021-03-26 | 1.74M shares 10-K · filed 2021-03-26 | |||||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-14 | 1.46M shares 10-Q · filed 2019-11-14 | 2.42M shares derived: sum of 4 quarters · filed 2020-03-30 | |||||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-13 | 1.46M shares 10-Q · filed 2019-08-13 | 2.42M shares derived: sum of 3 quarters · filed 2020-03-30 | 2.42M shares derived: sum of 4 quarters · filed 2020-03-30 | |||||
| 2019-03-31 | 1.46M shares 10-Q/A · filed 2019-05-20 | 2.42M shares derived: sum of 2 quarters · filed 2020-03-30 | 2.42M shares derived: sum of 3 quarters · filed 2020-03-30 | ||||||
| 2018-12-31 | 955.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 955.91K shares derived: sum of 2 quarters · filed 2020-03-30 | 2.03M shares 10-K · filed 2020-03-30 | ||||||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 1.08M shares 10-Q · filed 2018-11-14 | |||||||
| 2018-06-30 | 1.08M shares 10-Q · filed 2018-08-14 | ||||||||
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-11-14 | ||||||||
| 2016-12-31 | 1.96M shares 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |